The SPARE score reliably predicts the conversion from open partial to radical nephrectomy.


Journal

Croatian medical journal
ISSN: 1332-8166
Titre abrégé: Croat Med J
Pays: Croatia
ID NLM: 9424324

Informations de publication

Date de publication:
31 Oct 2021
Historique:
entrez: 3 11 2021
pubmed: 4 11 2021
medline: 6 11 2021
Statut: ppublish

Résumé

To assess the power of nephrometry scores to predict the intraoperative conversion from partial nephrectomy (PN) to radical nephrectomy (RN). We identified all the patients at our institution who were scheduled for PN between April 2012 and December 2017. Patients who underwent robotic or laparoscopic surgery were excluded. A total of 149 patients (94 men) who underwent open surgery and had complete data were included. The power of the R.E.N.A.L., PADUA, SPARE, and DAP scores to predict the conversion to RN, and the threshold values were assessed. In the multivariate analysis, the predictive power of the nephrometry scores was tested by separately including them in different models. The median age was 57 (48-67) years, while the median follow-up was 15 (7-29.5) months. The overall conversion rate was 10.7%. The optimal cut-off values for the R.E.N.A.L., PADUA, SPARE, and DAP scores were 7.5, 9.5, 5.5 and 7.5, respectively. The SPARE score had the highest area under the curve (AUC=0.807, P<0.001). In the multivariate analysis, the SPARE score had the highest odds ratio (OR 12.561; confidence interval 3.456-45.534, P<0.001]. A high SPARE score was significantly associated with the conversion to RN in patients who underwent open PN.

Identifiants

pubmed: 34730886
pmc: PMC8596471

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

464-471

Références

World J Urol. 2014 Jun;32(3):591-6
pubmed: 24700307
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
Urology. 2018 Jun;116:114-119
pubmed: 29578041
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Urol. 2009 Sep;182(3):844-53
pubmed: 19616235
Urology. 2012 Aug;80(2):347-53
pubmed: 22698478
J Urol. 2011 Apr;185(4):1204-9
pubmed: 21334022
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
J Urol. 2019 Nov;202(5):890-898
pubmed: 31145034
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1057-1069
pubmed: 28483780
World J Urol. 2017 Jan;35(1):73-80
pubmed: 27194142
Am J Kidney Dis. 2004 Jul;44(1):84-93
pubmed: 15211442
Urol Oncol. 2017 Dec;35(12):672.e7-672.e13
pubmed: 28889920
Eur Urol. 2009 Nov;56(5):786-93
pubmed: 19665284
Urology. 2018 Mar;113:85-90
pubmed: 29284123
Cancer. 2018 Oct 1;124(19):3839-3848
pubmed: 30207380
Urol Oncol. 2018 Mar;36(3):90.e15-90.e21
pubmed: 29223360
Eur Urol. 2017 Apr;71(4):606-617
pubmed: 27614693
J Urol. 2017 Jul;198(1):30-35
pubmed: 28087299
BJU Int. 2019 Apr 9;:
pubmed: 30963680
Urol Clin North Am. 2017 May;44(2):275-288
pubmed: 28411919
Semin Hematol. 2015 Oct;52(4):261-9
pubmed: 26404438
Eur Urol. 2015 May;67(5):913-24
pubmed: 25616710
BJU Int. 2018 Apr;121(4):565-574
pubmed: 29032581
J Urol. 2012 Aug;188(2):384-90
pubmed: 22698624
Indian J Urol. 2018 Jan-Mar;34(1):51-55
pubmed: 29343913

Auteurs

Hakan Bahadır Haberal (HB)

Hakan Bahadır Haberal, Gevher Nesibe Caddesi, Hacettepe University School of Medicine, 06230 Altındag, Ankara, Turkey, bahadirhaberal@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH